跳至主要内容
临床试验/ISRCTN75653261
ISRCTN75653261已完成未知

Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia

German CLL Study Group (GCLLSG)0 个研究点目标入组 375 人开始时间: 2005年4月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
375

研究概览

简要总结

  1. 2006 results in https://www.ncbi.nlm.nih.gov/pubmed/16219797 (added 25/01/2019) 2. 2007 results in https://www.ncbi.nlm.nih.gov/pubmed/17389338 (added 25/01/2019)

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with an age of up to 65 years with untreated CLL in advanced stage (all Binet stage C patients; Binet stage B with symptoms, which require therapy; Binet stage A with severe B-symptoms).

排除标准

  • Patients with an age less than 18 and more than 65 years were excluded as well as patients with any previous treatment of CLL, life expectancy less than six months and an Eastern Cooperative Oncology Group performance status of more than two. Patients were also excluded if they had severe organ dysfunction, concomitant or previous other neoplasms or
  • an autoimmune hemolytic anemia or thrombocytopenia.

研究者

发起方
German CLL Study Group (GCLLSG)

相似试验